CD2 and acute myeloid leukemia: This does not exclude CD2 as a relevant receptor for targeting of myeloid disease, as conventional NK cells were affected by the blocking antibody, but does suggest that the lower activation threshold of CIML NK cells leads to additional mechanisms being involved in mediating escape of AML from their effects.